Login
Companies $ARGX
$882.02 +$8.32 (0.95%) Pre-market
argenx SE logo

argenx SE

argenx.com

What Do They Do?

Develops and sells antibody medicines for people with autoimmune diseases.

Who Are Their Customers?

Public health institutions and government entities buy products through specialty distributors.

Do Revenues Turn Into Profits?

Yes. It kept 31 cents of every revenue dollar as net income in .

Net income,
31% of revenue
▲ +55% vs ($833M, 38%)

How Are They Changing?

Approved uses The earlier report describes VYVGART as approved for gMG; the latest lists approved uses in gMG, CIDP and ITP.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support